�??Go low�?� or say �??No�?� to aggressive systolic BP goals?
Metadata[+] Show full item record
The SPRINT trial demonstrated the benefits�??and risks�??of reaching a systolic target <120 mm Hg in non-diabetic patients at high risk for CV events. Here�??s who might benefit. Practice changer: Consider treating non-diabetic patients age �?�50 years to a systolic blood pressure (SBP) target <120 mm Hg as compared to <140 mm Hg when the benefits�??lower rates of fatal and nonfatal cardiovascular (CV) events and death from any cause�??are likely to outweigh the risks from possible additional medication.
Journal of Family Practice, 65(05) 2016: 342-344.